2012(7841);344:d7771
WRTV Investigates has learned the FDA sent 30 warning letters to telehealth companies for illegally marketing compounded GLP-1s
Encouraging safe use and reporting The FDA is urging patients to talk with their health care providers about any weight-loss medication and to report suspected side effects or quality concerns through its MedWatch program
Start your intake Understanding GLP-1 Medication Pricing Models GLP-1 medications come in two main categories: branded FDA-approved drugs and compounded formulations
The products are not intended to diagnose, treat, cure, or prevent any disease, and should not be used as a food, drug, cosmetic, or other household use
patients, telehealth platforms like Oana Health provide access to prescription-based treatments tailored to weight management and hormonal challenges associated with PCOS